Issue Information

ISTH Academy, Faculty / Presenters, 409361

Moving

ISTH Academy, Faculty / Presenters, 409362

Tissue factor at the crossroads of coagulation and radiation response in glioblastoma

ISTH Academy, Faculty / Presenters, 409363

Thromboinflammation in acute injury: infections, heatstroke, and trauma

ISTH Academy, Faculty / Presenters, 409364

COVID-19 outcomes in persons with hemophilia: results from a US-based national COVID-19 surveillance registry

ISTH Academy, Faculty / Presenters, 409370

Management of chemotherapy-induced thrombocytopenia: guidance from the ISTH Subcommittee on Hemostasis and Malignancy

ISTH Academy, , 409369

Timely identification for long-term impairment: a step further for postpulmonary embolism patients

ISTH Academy, , 409368

Evidence-based personalized thromboprophylaxis after major arthroplasty: a new horizon

ISTH Academy, Faculty / Presenters, 409367

Decoding thrombosis through code: a review of computational models

ISTH Academy, David Bark, 409366

Platelet-targeted gene therapy induces immune tolerance in hemophilia and beyond

ISTH Academy, , 409365

ISTH News and Updates: Join the ISTH Today

ISTH Academy, Faculty / Presenters, 408156

Coagulation factor VIII regulates von Willebrand factor homeostasis in vivo

ISTH Academy, X. Long Zheng, 408137

Corrigendum to ‘Evaluation of Venous Thromboembolism Risk Factors Reveals Subtype Heterogenicity in Children with Central Venous Catheters: A Multi-Center Study from the CHAT Consortium’ [Journal of Thrombosis and Haemostasis 21/9 (2023) 2441 - 2450]

ISTH Academy, Faculty / Presenters, 408155

Looking Back—And Forward

ISTH Academy, Faculty / Presenters, 408119

Crippling down factor IX for therapeutic gain

ISTH Academy, Mettine Bos, 408120

Genomic science of risk prediction for venous thromboembolic disease: convenient clarification or compounding complexity

ISTH Academy, Frits Rosendaal, 408121

The fibrinolysis renaissance

ISTH Academy, Faculty / Presenters, 408122

Antiplatelet strategies: past, present, and future

ISTH Academy, Michael Holinstat, 408123

Cellular stress and coagulation factor production: when more is not necessarily better

ISTH Academy, , 408124

Unraveling coagulation factor–mediated cellular signaling

ISTH Academy, Roger Preston, 408125

Commentary on “Structural analyses of β2-glycoprotein I: is there a circular conformation?”

ISTH Academy, Raimondo De Cristofaro, 408126

von Willebrand factor: aging is better?

ISTH Academy, Faculty / Presenters, 408127

Mechanisms and management of the coagulopathy of trauma and sepsis: trauma-induced coagulopathy, sepsis-induced coagulopathy, and disseminated intravascular coagulation

ISTH Academy, , 408128

Dynamic and functional linkage between von Willebrand factor and ADAMTS-13 with aging: an Atherosclerosis Risk in Community study

ISTH Academy, Jing-Fei Dong, 408129

Acquired von Willebrand disease in children undergoing extracorporeal membrane oxygenation: a prospective observational study

ISTH Academy, Heleen Van Ommen, 408130

Defining heparin resistance: communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis

ISTH Academy, Faculty / Presenters, 408154

Impact of N-glycan mediated shielding of ADAMTS-13 on the binding of pathogenic antibodies in immune thrombotic thrombocytopenic purpura

ISTH Academy, Jan Voorberg, 408132

Factor VIIa releases phosphatidylserine-enriched extracellular vesicles from endothelial cells by activating acid sphingomyelinase

ISTH Academy, Vijay Rao, 408133

Pharmacokinetic-guided versus standard prophylaxis in hemophilia: a systematic review and meta-analysis

ISTH Academy, Ingrid Pabinger, 408134

Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1

ISTH Academy, Faculty / Presenters, 408135

Postpartum hemorrhage in Sub-Saharan Africa—a prospective study in metropolitan Mozambique

ISTH Academy, Faculty / Presenters, 408136

Cattle-FRETS71, a novel fluorogenic substrate with broad applicability for characterizing ADAMTS13 properties and function

ISTH Academy, Joshua Muia, 408131

Functional determination of emicizumab in presence of factor VIII activity

ISTH Academy, Jens Müller, 408138

Postmortem diagnosis of severe factor X deficiency in a fetus with intracranial hemorrhage resulting in intrauterine death

ISTH Academy, Faculty / Presenters, 408139

Periprocedural management of type 2N von Willebrand disease with efanesoctocog alfa

ISTH Academy, Sol Schulman, 408140

Structural analyses of β-glycoprotein I: is there a circular conformation?

ISTH Academy, Nicola Pozzi, 408141

Coagulation factor VIIa enhances programmed death-ligand 1 expression and its stability in breast cancer cells to promote breast cancer immune evasion

ISTH Academy, Prosenjit Sen, 408142

Triple-positive antiphospholipid syndrome does not guarantee positivity in each lupus anticoagulant assay

ISTH Academy, Faculty / Presenters, 408143

Projected impact of guidelines on incidence of venous thromboembolism after cesarean delivery in the United States

ISTH Academy, Faculty / Presenters, 408144

Design and characterization of novel activated protein C variants for the proteolysis of cytotoxic extracellular histone H3

ISTH Academy, Gerry Nicolaes, 408145

The TFPIα C-terminal tail is essential for TFPIα-FV-short-protein S complex formation and synergistic enhancement of TFPIα

ISTH Academy, Josefin Ahnstrom, 408146

Antithrombotic management of patients with deep vein thrombosis and venous stents: an international registry

ISTH Academy, James Douketis, 408147

Fibrinogenolysis and fibrinolysis in vaccine-induced immune thrombocytopenia and thrombosis

ISTH Academy, Nicola Mutch, 408148

SINE-VNTR-Alu retrotransposon insertion as a novel mutational event underlying Glanzmann thrombasthenia

ISTH Academy, , 408149

New insights into the binding of PF4 to long heparin oligosaccharides in ultralarge complexes using mass spectrometry

ISTH Academy, , 408150

PACSIN2 regulates platelet integrin β1 hemostatic function

ISTH Academy, Herve Falet, 408151

A regulatory node involving Gα, PLCβ, and RGS proteins modulates platelet reactivity to critical agonists

ISTH Academy, Peisong Ma, 408152

Thrombin receptor PAR1 silencing in endothelial colony–forming cells modifies stemness and vasculogenic properties

ISTH Academy, Faculty / Presenters, 408153

COVID-19 and Thrombosis: An Update

ISTH Academy, Faculty / Presenters, 403913

Short - COVID-19 and Thrombosis: An Update

ISTH Academy, Faculty / Presenters, 408158

SSC on the Case: Pediatric and Neonatal Thrombosis and Hemostasis

ISTH Academy, Faculty / Presenters, 405877

From Guidance to Practice: Management of Chemotherapy Induced Thrombocytopenia

ISTH Academy, Gerald Soff, 405878

Sex Matters: Policy on Reporting Sex as a Biological Variable at Research and Practice in Thrombosis and Hemostasis

ISTH Academy, , 409265

How We Write a Manuscript Discussion

ISTH Academy, Mary Cushman, 409266

Heparin-induced thrombocytopenia (and autoimmune heparin-induced thrombocytopenia): an illustrious review

ISTH Academy, Theodore (Ted) Warkentin, 409267

A need to refine venous thromboembolism risk assessment: the challenge of optimizing patient selection for thromboprophylaxis among hospitalized adults

ISTH Academy, , 409268

Treatment of chemotherapy-induced thrombocytopenia with monotherapy versus combination therapy: the devil is in the details

ISTH Academy, Hanny Al-Samkari, 409269

Heavy menstrual bleeding in adolescents: a primary issue in primary care

ISTH Academy, Angela Weyand, 409270

The crux of menopausal hormone therapy: dose, route, and age

ISTH Academy, Lisa Baumann Kreuziger, 409271

Use of direct oral anticoagulants for venous thromboembolism treatment at extremes of body weight, renal and liver function: an illustrated review

ISTH Academy, , 409272

Investigating patients for bleeding disorders when most of the “usual” ones have been ruled out

ISTH Academy, Johanna Gebhart, 409273

Immune cell–mediated venous thrombus resolution

ISTH Academy, Faculty / Presenters, 409274

What can historical literature on von Willebrand disease teach us?

ISTH Academy, Faculty / Presenters, 409275

D-dimer predicts venous thromboembolism in multiple myeloma: a nested case-control study

ISTH Academy, Faculty / Presenters, 409276

Venous thromboembolism among physically active young adult females

ISTH Academy, Anna Gurevich-Shapiro, 409277

Posttraumatic stress disorder and posttraumatic stress symptoms among adults with hemophilia A and B

ISTH Academy, Faculty / Presenters, 409278

Antiphospholipid syndrome in rural, remote, and First Nations peoples in the Top End of the Northern Territory, Australia

ISTH Academy, , 409279

Factor IX administration in the skin primes inhibitor formation and sensitizes hemophilia B mice to systemic factor IX administration

ISTH Academy, Radek Kaczmarek, 409280

Vaccine-induced immune thrombotic thrombocytopenia post COVID-19 booster vaccination in Brazil: a case series

ISTH Academy, Faculty / Presenters, 409281

Breakthrough infections after COVID-19 vaccinations do not elicit platelet hyperactivation and are associated with high platelet–lymphocyte and low platelet–neutrophil aggregates

ISTH Academy, Lucia Stefanini, 409282

Reassessment of dextran sulfate in anti-Xa assay for unfractionated heparin laboratory monitoring

ISTH Academy, François Mullier, 409283

Race, ethnicity, and immune tolerance induction in hemophilia A in the United States

ISTH Academy, Faculty / Presenters, 409284

Inhibitor development according to concentrate in severe hemophilia: reporting on 1392 Previously Untreated Patients from Europe and Canada

ISTH Academy, , 409285

Intracardiac thrombi in pediatrics: anticoagulation approach and treatment outcomes

ISTH Academy, Faculty / Presenters, 409286

The World Federation of Hemophilia World Bleeding Disorders Registry: insights from the first 10,000 patients

ISTH Academy, Faculty / Presenters, 409287

Factors XI and XII in extracorporeal membrane oxygenation: longitudinal profile in children

ISTH Academy, Faculty / Presenters, 409288

Guiding warfarin self-management in children: development of a warfarin nomogram

ISTH Academy, , 409289

Serious bleeds in pediatric persons with hemophilia A on emicizumab prophylaxis

ISTH Academy, , 409290

Emicizumab use in females with moderate or mild hemophilia A without factor VIII inhibitors who warrant prophylaxis

ISTH Academy, Faculty / Presenters, 409291

Effect of emicizumab-neutralizing antibodies on activated partial thromboplastin time–based clotting time test results in patients treated with emicizumab

ISTH Academy, Flora Peyvandi, 409292

Factor V Leiden interferes with protein S activity assay

ISTH Academy, Agathe Herb, 409293

COVID-19. Comparison of D-dimer levels measured with 3 commercial platforms

ISTH Academy, Armando Tripodi, 409294

Western blot and immunohistochemical analysis of mouse tissue factor

ISTH Academy, Faculty / Presenters, 409295

Artificial intelligence for venous thromboembolism prophylaxis: Clinician perspectives

ISTH Academy, Rushad Patell, 409296

Therapeutic-dose heparin in preventing COVID-19–associated acute kidney injury: What about bleeding risk?

ISTH Academy, , 409297

Corrigendum to ‘Recurrent venous thromboembolism in hospitalized children with a history of prior venous thromboembolism: a report from the Children’s Hospital-Acquired Thrombosis Consortium’ [Research and Practice in Thrombosis and Haemostasis Volume 7, Issue 5, July 2023, 102139]

ISTH Academy, Faculty / Presenters, 409298

Issue Information

ISTH Academy, Faculty / Presenters, 409264

APC-PAR1-R46 signaling limits CXCL1 expression during poly IC-induced airway inflammation in mice

ISTH Academy, Silvio Antoniak, 405652

MAGT1 deficiency in XMEN disease is associated with severe platelet dysfunction and impaired platelet glycoprotein N-glycosylation

ISTH Academy, Frédéric Adam, 405651

Characterization of all small RNAs in and comparisons across cultured megakaryocytes and platelets of healthy individuals and COVID-19 patients

ISTH Academy, , 405650

Amplified inhibition of atherosclerotic plaque-induced platelet activation by glenzocimab with dual antiplatelet therapy

ISTH Academy, , 405649

Branched-chain amino acids promote thrombocytopoiesis by activating mTOR signaling

ISTH Academy, Yanyan Xu, 405648

Mechanisms regulating heterogeneity of hemostatic gene expression in endothelial cells

ISTH Academy, , 405628

The prothrombotic tendency of metabolic-associated fatty liver disease

ISTH Academy, Faculty / Presenters, 405627

A review of the rationale for gene therapy for hemophilia A with inhibitors: one-shot tolerance and treatment?

ISTH Academy, Faculty / Presenters, 405626

Role of red blood cells in clinically relevant bleeding tendencies and complications

ISTH Academy, Faculty / Presenters, 405625

Risk stratification of acute pulmonary embolism

ISTH Academy, Faculty / Presenters, 405624

Fibrinogen and fibrin: synthesis, structure, and function in health and disease

ISTH Academy, Alisa Wolberg, 405623

TMEM16E: unscrambling our knowledge about coagulation

ISTH Academy, Rinku Majumder, 405622

Disseminating information on coagulation (DIC)/bleeding—the hemostatic balance of social media throughout the years

ISTH Academy, Dianne Van Der Wal, 405621